OPN4 and Alzheimer disease: Finally, Kawasaki et al. performed a pilot sub-study from a prospective study on biomarkers in the early stages of AD, using chromatic pupillometry under photopic conditions to assess primarily cones and melanopsin-mediated pupillary responses.